Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Five researchers in the Department of Psychiatry are in the top one percent of the Highly Cited Researchers 2019 list.

The 2019 list of Highly Cited Researchers, which recognises the world's most influential researchers of the past decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in Web of Science, is now published.

Those recognised and leading world-class research and teaching, helping to translate advances in science into better mental health for all, at the Department of Psychiatry include:

John Geddes - Professor of Epidemiological Psychiatry and Head of Department

Guy Goodwin - Senior Research Fellow

Willem Kuyken - Sir John Ritblat Family Foundation Professor of Mindfulness and Psychological Science

Seena Fazel - Wellcome Trust Senior Research Fellow

Mark Woolrich - Professor of Computational Neuroscience

 

Read more (Department of Psychiatry website)

Similar stories

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

Clinical Trials Coronavirus COVID-19 General Research

The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.

Ancient gene mutation found to cause rare hereditary condition

General Research

UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).